Current status of regenerative medicine in osteoarthritis: stem cells, exosomes, and genes
The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells,...
Main Author: | Gun-Il Im |
---|---|
Format: | Article |
Language: | English |
Published: |
The British Editorial Society of Bone & Joint Surgery
2021-02-01
|
Series: | Bone & Joint Research |
Subjects: | |
Online Access: | https://online.boneandjoint.org.uk/doi/epdf/10.1302/2046-3758.102.BJR-2020-0517.R1 |
Similar Items
-
Emerging Potential of Exosomes in Regenerative Medicine for Temporomandibular Joint Osteoarthritis
by: Yeon-Hee Lee, et al.
Published: (2020-02-01) -
Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)—An In Vivo Animal Trial
by: Robert Köhnke, et al.
Published: (2021-01-01) -
Applications, challenges and prospects of mesenchymal stem cell exosomes in regenerative medicine
by: Aysa Rezabakhsh, et al.
Published: (2021-09-01) -
Cell-free Stem Cell-Derived Extract Formulation for Regenerative Medicine Applications
by: Ashim Gupta, et al.
Published: (2020-12-01) -
Adipose-Derived Mesenchymal Stem Cells: Are They a Good Therapeutic Strategy for Osteoarthritis?
by: Elena Damia, et al.
Published: (2018-06-01)